Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Marie-Claire Rassweiler-Seyfried is a pioneering urologic surgeon whose research sits at the cutting edge of minimally invasive surgery, particularly in the domains of endourology, robotic surgery, and laser technology. Her work critically evaluates the evolving landscape of stone disease management, notably through her highly cited 2020 paper questioning the contemporary role of extracorporeal shock-wave lithotripsy (ESWL) against the rise of flexible ureterorenoscopy (FURS) and percutaneous nephrolithotomy (PCNL). She has also made significant contributions to benign prostatic hyperplasia (BPH) treatment, leading a 2023 propensity score-matched analysis comparing Thulium laser enucleation (ThuLEP) to robot-assisted simple prostatectomy (RASP) for large glands. Beyond comparative effectiveness, Dr. Rassweiler-Seyfried is a leading voice on the future of the field, authoring comprehensive reviews on the state of robotic-assisted flexible ureterorenoscopy and the historical evolution of minimal-invasive urology. Her work on perioperative antibiotic prophylaxis in radical prostatectomy addresses a critical gap in clinical guidelines. With over 50 citations across her most impactful papers, she is actively shaping the transition from traditional open and laparoscopic techniques to advanced robotic and laser-based paradigms, establishing herself as a key authority on the future of urologic surgery.